When should TSH be rechecked after initiating levothyroxine therapy?

When to Recheck TSH After Starting Levothyroxine

Recheck TSH 6 to 8 weeks after initiating levothyroxine therapy in adult patients with primary hypothyroidism. 1

Adult Patients (Non-Pregnant)

Initial Monitoring Timeline

• Measure TSH at 6–8 weeks after starting levothyroxine or after any dose adjustment 1
• This interval allows levothyroxine to reach steady-state given its long half-life 2, 3

Rationale for 6–8 Week Interval

The FDA labeling explicitly states this timeframe for adults with primary hypothyroidism, reflecting the pharmacokinetics of levothyroxine and the time required for pituitary-thyroid axis equilibration 1. Checking earlier may yield misleading results as steady-state has not been achieved 3.

After Dose Stabilization

• Once TSH is within target range on a stable dose, monitor every 6–12 months 1
• Recheck sooner if clinical status changes or symptoms develop 1

Pregnant Patients

More Frequent Monitoring Required

• Check TSH every 4 weeks after initiating or adjusting levothyroxine until TSH stabilizes within trimester-specific reference range 4, 1
• After stabilization, reduce frequency to once per trimester 4
• Postpartum monitoring: Check TSH 4–8 weeks after delivery (after reducing dose to pre-pregnancy levels) 1

Critical Importance in Pregnancy

Untreated or undertreated hypothyroidism in pregnancy increases risks of preeclampsia, low birth weight, fetal loss, and adverse neurodevelopmental outcomes in offspring 4. The more aggressive monitoring schedule (every 4 weeks vs. 6–8 weeks in non-pregnant adults) reflects these serious maternal and fetal consequences.

Pediatric Patients

Intensive Early Monitoring

• Check TSH and total or free-T4 at 2 and 4 weeks after starting levothyroxine 1
• Recheck 2 weeks after any dose change 1
• After stabilization, monitor every 3–12 months until growth is completed 1

Red Flags Requiring Earlier Reassessment

• Failure of T4 to increase into upper half of normal range within 2 weeks 1
• Failure of TSH to decrease below 20 mIU/L within 4 weeks 1
• These findings suggest inadequate therapy and warrant assessment of compliance, dosing accuracy, and administration method before increasing the dose 1

Special Populations

Secondary/Tertiary Hypothyroidism

• Monitor serum free-T4 levels (not TSH) at 6–8 week intervals 1
• Target: maintain free-T4 in upper half of normal range 1

Subclinical Hypothyroidism

• If treatment is initiated, recheck TSH 2 months after starting levothyroxine 2
• For patients started on trial therapy for symptoms, review response at 3–4 months after achieving target TSH; discontinue if no symptom improvement 2

Common Pitfalls to Avoid

Do Not Check Too Early

• Checking TSH before 6 weeks in adults leads to premature dose adjustments based on incomplete equilibration 3
• The long half-life of levothyroxine (approximately 7 days) necessitates patience 3

Do Not Ignore Absorption Issues

• If TSH remains elevated despite apparently adequate dosing, consider malabsorption, non-adherence, or drug interactions before simply increasing the dose 1, 5
• Supervised absorption testing may be needed in refractory cases 5

Pregnancy Requires Immediate Action

• Confirm pregnancy and check TSH/free-T4 as soon as pregnancy is confirmed 1
• Do not wait 6–8 weeks for first check in pregnant patients—use the 4-week interval from the start 4, 1

Pediatric Undertreatment Has Serious Consequences

• In children, undertreatment adversely affects cognitive development and linear growth 1
• The earlier monitoring schedule (2 and 4 weeks) is essential to prevent developmental harm 1